Sectors

RKDA
Arcadia Biosciences, Inc.
0.53
2 x 0.37
2 x 0.67
bid
ask
-
0.00
0.42%
02:08 PM
timesize
Ytd-73.34%
1y-86.33%
0.48
day range
0.54
0.38
52 week range
6.71
Open0.54Prev Close0.53Low0.48High0.54Mkt Cap1.27M
Vol55.49KAvg Vol2.13MEPS-4.54P/EN/AForward P/E-4.76
Beta0.56Short Ratio0.73Inst. Own4.70%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning03-1950-d Avg0.64200-d Avg1.661yr Est9.00
Income Statement
Total Revenue1.44M
Revenues (USD)1.44M
Cost of Revenue812.00K
Gross Profit631.00K
Operating Expenses1.13M
Selling, General and Administrative Expense1.13M
Operating Income-496.00K
Net Income-6.27M
Net Income Common Stock-6.27M
Net Income Common Stock (USD)-6.27M
Consolidated Income-6.27M
Earnings per Basic Share-2.09
Earnings per Basic Share (USD)-2.09
Earnings per Diluted Share-2.09
Earning Before Interest & Taxes (EBIT)-6.27M
Earning Before Interest & Taxes (USD)-6.27M
Weighted Average Shares2.99M
Weighted Average Shares Diluted2.99M
Balance Sheet
Cash and Equivalents4.18M
Cash and Equivalents (USD)4.18M
Trade and Non-Trade Receivables559.00K
Current Assets5.74M
Total Assets5.89M
Current Liabilities1.65M
Total Liabilities5.26M
Accumulated Retained Earnings (Deficit)-291.87M
Shareholders Equity633.00K
Shareholders Equity (USD)633.00K
Assets Non-Current154.00K
Goodwill and Intangible Assets39.00K
Inventory930.00K
Liabilities Non-Current3.61M
Trade and Non-Trade Payables1.38M
Cash Flow
Net Cash Flow from Financing3.54M
Net Cash Flow / Change in Cash & Cash Equivalents3.22M
Issuance (Purchase) of Equity Shares3.94M
Net Cash Flow from Operations-319.00K
Share Based Compensation14.00K